Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Pain. 2010 Dec 30;152(3):599–606. doi: 10.1016/j.pain.2010.11.029

Genomic loci and candidate genes underlying inflammatory nociception

Harsha K Nair 1, Heather Hain 2,3, Raymond M Quock 4, Vivek M Philip 5, Elissa J Chesler 5, John K Belknap 2, William R Lariviere 1,*
PMCID: PMC3039031  NIHMSID: NIHMS262046  PMID: 21195549

Abstract

Heritable genetic factors contribute significantly to inflammatory nociception. To determine candidate genes underlying inflammatory nociception, the current study used a mouse model of abdominal inflammatory pain. BXD recombinant inbred (RI) mouse strains were administered the intraperitoneal (IP) acetic acid test and genome-wide quantitative trait locus (QTL) mapping was performed on the mean number of abdominal contraction and extension movements in three distinct groups of BXD RI mouse strains in two separate experiments. Combined mapping results detected two QTLs on chromosomes (Chr) 3 and 10 across experiments and groups of mice; an additional sex-specific QTL was detected on Chr 16. The results replicate previous findings of a significant QTL, Nociq2, on distal Chr 10 for formalin-induced inflammatory nociception and will aid in identification of the underlying candidate genes. Comparisons of sensitivity to IP acetic acid in BXD RI mouse strains with microarray mRNA transcript expression profiles in specific brain areas detected covarying expression of candidate genes that are also found in the detected QTL confidence intervals. The results indicate that common and distinct genetic mechanisms underlie heritable sensitivity to diverse inflammatory insults, and provide a discrete set of high priority candidate genes to investigate further in rodents and human association studies.

Keywords: inflammation, nociception, acetic acid, quantitative trait locus mapping, microarray, transcript abundance

1. Introduction

Understanding what predisposes patients to increased inflammatory pain sensitivity may improve prediction and prevention of suffering and improve patient care. Rodent studies have demonstrated that genetic background significantly affects sensitivity to a number of inflammatory insults [23,52]. Although many genes have been implicated in the modulation of inflammatory nociception using knockout mouse and other techniques [20], the genes responsible for heritable individual differences are largely unknown. Quantitative trait locus (QTL) mapping of somatic inflammatory nociception in the intraplantar formalin test has detected two genomic loci, Nociq1 and Nociq2, linked to heritable differences on chromosomes (Chr) 9 and 10 of the mouse, respectively [52]. Analysis of congenic mouse strains has detected a third QTL on Chr 12, Nociq3 [32]. Within these genomic regions are candidate genes that underlie heritable variability in inflammatory nociception. The candidate gene, Atp1b3, has been identified as likely responsible for Nociq1 and sensitivity in the early phase of the biphasic formalin response of paw licking [21]. The responsible candidate genes underlying the second, late phase of formalin responding traditionally ascribed more to tissue inflammation than the early phase [47] remain to be identified.

Visceral inflammatory pain or nociception and the underlying mechanisms differ in significant ways from somatic inflammatory pain or nociception [38]. The precise molecular mechanisms that underlie these differences are still under investigation. Previous findings, however, also suggest that sensitivity to somatic and certain visceral inflammatory insults share underlying genetic mechanisms as they are genetically correlated in standard inbred strains of mice [23,33]. Standard inbred mouse strains that are more sensitive to subcutaneous (SC) injection of formalin, bee venom or capsaicin are also more sensitive to intraperitoneal (IP) injection of acetic acid or magnesium sulfate; Spearman rank correlation coefficients between spontaneous inflammatory nociceptive behaviors in these somatic and visceral models range from 0.41 – 0.79, with a mean and median of 0.64 [23,33]. These genetic correlations indicate that common genetic mechanisms are shared among the pain models [18], despite differences in the inflammatory irritant, the site of administration, and the behavioral response [33]. Identification of the common mechanisms among these pain models will help prioritize the search for the most broadly acting candidate genes for inflammatory nociception and pain.

The current study examines the genetics of inflammatory nociception using QTL mapping to detect regions of the mouse genome and candidate genes linked with sensitivity to IP injection of acetic acid in multiple panels of recombinant inbred (RI) strains of mice. In addition, genetic correlation analysis of acetic acid-induced responding with tissue-specific transcript expression profiles is performed to obtain convergent evidence for candidate genes found in the detected QTLs.

2. Methods

2.1. Subjects

Mice of C57BL/6J, DBA/2J and 24 BXD RI (all “/TyJ”) strains were used in the experiments. BXD RI mice have been created by crossing the standard inbred strains C57BL/6J and DBA/2J and re-inbreeding the F2 hybrid offspring [45]; they have been maintained inbred since their creation. These RI strains represent a genetic reference population with a fixed genotype for which genotype, phenotype, and transcript data collected over time and across experiments are directly comparable [9].

Mice were tested in two separate experiments performed independently and at different times and locations. This provided the opportunity to quantitatively test for convergence of findings from two distinct experiments with the same hypothesis. The HHF and HHM groups of mice were tested at the Portland Veterans Affairs Medical Center Veterinary Medical Unit by author H.H. The RMQ group of mice was tested at the University of Illinois College of Medicine at Rockford by author R.M.Q. as part of a previously published report [37]. All procedures were approved by the IACUC of the institutions and all experiments adhered to the guidelines of the Committee for Research and Ethical Issues of the IASP [53].

Male mice in the RMQ group were obtained from The Jackson Laboratory (JAX, Bar Harbor, Maine) and tested at least one week after arrival (n = 4–10/strain; N = 122). Mice from the HHF and HHM groups were female and male offspring, respectively, from matings of mice of the same strain obtained from JAX and tested after at least one week of acclimation to the final housing facility (n = 6–13/strain/sex; N = 240 for HHF, 233 for HHM). The sexes were separated at weaning at 21–25 days of age and housed 1–4 mice per shoebox cage. Single housing was avoided when possible and testing was avoided for 24 h after a clean cage change. Food and water were available ad libitum. The colony rooms were on a 12 h light/dark cycle. All mice were at least six weeks of age when tested. HHF and HHM mice were previously tested for analgesia in the acetic acid test seven to nine days prior. Testing seven to ten days prior does not have a significant effect on responses in the acetic acid test [37].

2.2 Acetic acid inflammatory nociception assay

For the HHF and HHM groups, glacial acetic acid (EM Science, Gibbstown, NJ) was diluted with 0.9% saline to a final concentration of 0.65% made fresh each week. For the RMQ group, a final concentration of 0.6% acetic acid solution was used. All mice were acclimated to the procedure room for at least one hour prior to testing. Testing was done between the hours of 10:00 and 16:00. HHF and HHM groups of mice were placed in Plexiglas® cylinders (29 cm×30 cm diameter) on a counter top for 30 min, injected with saline (SC, 10 ml/kg; vehicle injection for separate analgesia study), and 20 min later acetic acid was injected (IP, 10 ml/kg). HHF and HHM mice were placed in the cylinders and observed continuously for 30 min after injection of the acetic acid for the number of abdominal contraction and extension movements. These abdominal extensions (also referred to as ‘writhes’), defined as lengthwise constrictions of the torso with a concomitant concave arching of the back, are quite stereotypical and are easily distinguished from other behaviors. One to four mice were observed and scored at a time, which was possible because a single response lasts several seconds and the frequency is low, on average < 2/min. Up to five sets of four mice were observed per day. RMQ mice were observed and scored continuously for six minutes beginning five minutes after acetic acid injection (i.e. 5–11 min after injection). The slight differences in parameters used for HHF, HHM and RMQ groups do not preclude combination of the data with Fisher’s method described below in section 2.5. [44]. In fact, the current study is partly intended to determine linkage of genomic regions and candidate genes to inflammatory nociception despite methodological differences (including, more broadly, differences between acetic acid and formalin assays).

2.3. Statistical analysis of strain differences and heritability estimates

The effect of BXD RI mouse strain on mean number of abdominal extensions was determined by a one-way analysis of variance (ANOVA). Heritability was determined as h2 = VA/(VA + VE), where VA is the additive genetic variation estimated by the between-strain variance and VE is the environmental variance estimated by the within-strain variance from the ANOVA results [14]. Note that the additive genetic variance, when estimated using isogenic BXD RI strains, also contains gene-by-gene and gene-by-environment interactions, and that environmental variance is confounded with any technical variation. This estimate does not directly estimate the transmission of phenotypic values from parent to offspring, but provides an estimate of the resemblance among isogenic relatives.

2.4. Quantitative trait locus (QTL) mapping

To determine regions of the genome containing polymorphisms of relevance to variability in inflammatory nociception, whole-genome single locus QTL mapping of the BXD strain means was performed for each of the groups, HHF, HHM and RMQ. DNA marker-trait associations were assessed by regression analysis using the QTL detection software package, Map Manager QTX [27,28] as integrated with the GeneNetwork/WebQTL website (www.genenetwork.org; www.webqtl.org) [51]. Interval maps of the associations across the genome were constructed using the online software WebQTL (www.genenetwork.org) [4,51]. A total of 3795 non-redundant DNA markers polymorphic between the parental C57BL/6J and DBA/2J strains were considered (June 2005 freeze; www.genenetwork.org/dbdoc/BXDGeno.html). The threshold logarithm of the odds (LOD) score for a significant QTL was determined using an empirical p-value from 1000 permutations of the strain means with a genome-wide error rate α = 0.05 [7].

When two loci were detected in close proximity to each other, multiple-QTL modeling was performed to determine whether the loci are independent of one another in explaining variation in mean responses to IP acetic acid. Multiple QTL model fitting was performed using functions available in the R/QTL package (R version 2.11.1, R/QTL 1.18–7). An additive model incorporating the two loci was fit and p-values for individual model terms were obtained by dropping them one at a time. This determines the relative importance of the individual terms in the model and determines whether a more parsimonious single QTL model is sufficient to explain the observed phenotypic variance.

2.5. Fisher’s method of combining results of multiple related experiments

Fisher’s method of combining probabilities of multiple independent experiments permits the statistical results of highly related experiments testing the same hypothesis to be combined quantitatively [44]. This method has been used successfully to determine the robustness of results in replicate QTL mapping studies for other pain traits including swim stress-induced analgesia [31]. Note that slight differences in experimental design are acceptable with this approach [44], and hence, the slight differences between experiments in acetic acid concentration used (0.6% or 0.65%) and total time of the observation period (6 or 30 min) do not preclude use of the method. In fact, for the current study, the method permits the determination of QTL mapping results that are robust to these slight differences, and thus, highly unlikely to be due to chance. For each of the HHF, HHM, and RMQ groups, the p-value of the Pearson product-moment correlation coefficient between DNA marker values (0 or 1 for C57BL/6J or DBA/2J homozygotes, respectively) and strain means of number of abdominal extensions was calculated for each marker. For each marker, the p-value results from the three mapping populations, the HHF, HHM, and RMQ groups, were combined using the formula χ2 = −2Σ ln p. This χ2 value is then compared to an inverse χ2 distribution with 2(3 independent tests) = 6 degrees of freedom (df) to yield a combined p-value. Bonferroni correction for the 3795 genome-wide comparisons renders the critical p-value (0.05/3795) = 1.32×10−5, which corresponds to a critical χ2 value of 32.48 with 6 df.

2.6. Transcript covariance analysis

Transcript covariance with the trait provides an indication of the momentary effective genotype or transcriptional context in which sensitivity to a trait is determined [29] and can be used to empirically reduce the list of candidate genes from QTL mapping results [12]. Genetic correlation analysis was performed against microarray measures of transcript abundance to determine which transcripts’ expression covaries with strain means of sensitivity to acetic acid. Because the BXD RI strains of mice are a genetic reference population with fixed, segregated genotypes, phenotypic measurements can be combined over time and across studies. High positive correlations between acetic acid responding and gene expression for the same strains of mice indicate shared genetic mechanisms between the trait and the gene’s expression [9,18]. Basal tissue-specific mRNA transcript expression levels have been determined with microarray methods for several brain areas of up to 67 BXD RI strains, including the 24 strains tested here, and are publicly available on the GeneNetwork website (www.genenetwork.org) [4,51]. Pearson product-moment correlations were calculated between strain means of abdominal extensions and transcript expression values in publicly available Affymetrix or Illumina genome-wide mRNA microarray data for the cerebellum, hippocampus, whole neocortex, prefrontal cortex, nucleus accumbens, and the striatum of BXD RI strains [3,5,6,35]. These brain areas have been implicated in the modulation of sensory processes and responses to analgesic treatments, including from human brain imaging studies [1,2,13,17,40,46]. The data sets and complete methodological details for each microarray study are available on the GeneNetwork website (www.genenetwork.org). All samples were obtained from experimentally naïve adult mice. Comparisons were made with the most recent version of the microarray data for each tissue with RMA normalization when multiple normalizations were available. With the goal of prioritization of candidate genes identified with QTL mapping, a conservative critical p = 0.0001 was chosen as this provides a reasonable, expected range of number of correlated transcripts for a single brain area based on previous whole genome transcript expression studies of sensory traits [8,16] and has been shown to identify results that are reproducible with other molecular methods [36].

3. Results

3.1. Strain differences and heritability estimates

A wide range of sensitivity to IP acetic acid was observed among BXD RI mouse strains with 4.65, 6.12 and 5.05 fold ranges observed in mean responses in the HHF, HHM and RMQ groups, respectively (Fig. 1). Overall, there was a significant effect of group on responses (F2,531 = 84.42, p < 0.0001) and a significant effect of strain in the RMQ group (F21,100 = 6.25, p < 0.0001). Considering only the HHF and HHM groups, there was only a tendency toward a significant interaction of sex×strain (F24,411 = 1.38, p = 0.11), but a significant effect of sex (F1,410 = 37.98, p < 0.0001) and a significant effect of BXD RI strain (F24,410 = 4.27, p < 0.0001). Heritability estimates indicate that strain differences account for 31%, 25% and 57% of the variation in the HHF, HHM and RMQ groups, respectively.

Figure 1.

Figure 1

Mean number of responses of BXD RI strains to IP acetic acid injection 0–30 min (HHF and HHM) or 6–11 min after injection (RMQ). BXD RI strain had a significant effect on responses (p < 0.0001). There was a significant effect of group (HHF, HHM and RMQ; p < 0.0001) with the RMQ group displaying the least responses and female mice (HHF) responding more than males observed for the same period of time (HHM).

3.2. QTL mapping

The interval maps in Figs. 24 show genomic regions linked to inflammatory nociception in the IP acetic acid assay. For the individual groups, a statistically significant QTL was detected on proximal Chr 16 (HHM group) and four suggestive QTLs were detected: one on Chr 16 just proximal to the significant QTL on Chr 16 (HHM group), one on mid-Chr 3 (RMQ group), and two on distal Chr 10 (HHM and RMQ groups) (Figs. 24). Fisher’s method was applied to combine the results of the three groups and test whether individual group results that reached the level of statistically suggestive were consistently observed across groups and thus unlikely due to chance. Fisher’s method detected statistically significant linkage on mid-Chr 3 and distal Chr 10 and a third QTL slightly below significance just proximal to the significant QTL on Chr 10 (Figs. 2 and 3). These QTL regions contain polymorphic genes responsible for variation in sensitivity to inflammatory nociception evoked by IP acetic acid. The regions of the significant QTLs on Chr 3 (54.93–60.47 Mb; Fig. 2), Chr 10 (119.90–122.07 Mb; Fig. 3) and Chr 16 (19.92–22.81 Mb; Fig. 4) contain 26, 12 and 33 known candidate genes, respectively (Table 1) using a 1.5 LOD drop-off from the peak of the QTL or a 101.5-fold drop-off of Fisher’s combined p-value (with χ2 distribution). Note that a 1.5 LOD drop-off was used to determine confidence intervals as the conventional 1.0 LOD drop-off [22] has been criticized as biased, overly conservative, and possibly excluding true candidate genes [25,26,49,50].

Figure 2.

Figure 2

Interval mapping of acetic acid response strain means on Mus musculus chromosome 3 (only 40–80 Mb from centromere shown). LOD scores for the genotype-phenotype associations for each group are indicated by the red (HHF), blue (HHM), and green (RMQ) traces using the right y-axis. Permutation-based suggestive LOD score thresholds are indicated by the dotted line of corresponding color determined for each group based on 1000 permutations of the strain means of the group. A statistically significant QTL was detected at 54.93–60.47 Mb for the combined results of the individual groups using Fisher’s method and Bonferroni correction (left y-axis, critical χ2 value of 32.48 with 6 df, p = 1.32 × 10−5, indicated by dotted black line). Points on line for Fisher’s combined p-value indicate location of DNA marker.

Figure 4.

Figure 4

Interval mapping of acetic acid response means on chromosome 16 (only 5–35 Mb from centromere shown). Suggestive LOD score thresholds are indicated by the dotted line of corresponding color determined for each group based on 1000 permutations of the strain means of the group; the upper dotted blue line indicates the statistically significant LOD score threshold for the HHM group. Fisher’s method did not detect a significant QTL for the combined results of the individual groups. A significant QTL was detected for the HHM group at 19.92–22.81 Mb that was not detected in the HHF group. See Fig. 2 legend for more information.

Figure 3.

Figure 3

Interval mapping of acetic acid response means on chromosome 10 (only 94–128 Mb from centromere shown). A statistically significant QTL was detected at 119.90–122.07 Mb for the combined results of the individual groups using Fisher’s method (black trace; left y-axis). A second QTL slightly below significance was detected just proximal to the significant QTL. See Fig. 2 legend for more information.

Table 1.

Known candidate genes in confidence intervals of significant QTLs for acetic acid-induced inflammatory nociception. Genes indicated with bold font also show high transcript covariance with acetic acid response means (see Tables 2 and 3).

Chr 3
(54.93–60.47 Mb)

Spg20
Sohlh2
Dclk1
Nbea
Mab21l1
Tm4sf1
Tm4sf4
Wwtr1
Commd2
Gm410
Rnf13
Pfn2
Tsc22d2
Gdap9
Eif2a
Siah2
Clrn1
Gpr171
P2ry14
Gpr87
P2ry13
P2ry12
Igsf10
Aadac
Sucnr1
Mbnl1

Chr 10
(119.90–122.07 Mb)

Hmga2
Msrb3
Lemd3
Wif1
Tbc1d30
Gns
Rassf3
Tbk1
Xpot
Srgap1
Tmem5
Avpr1a

Chr 16
(HHM only)
(19.92–22.81 Mb)

Klhl6
Klhl24
Yeats2
Map6d1
Parl
Cyp2ab1
Abcc5
Eif2b5
Dvl3
Ap2m1
Abcf3
Alg3
Ece2
Camk2n2
Psmd2
Eif4g1
Clcn2
Polr2h
Thpo
Chrd
Ephb3
Magef1
Vps8
Ehhadh
Tmem41a
Liph
Map3k13
Senp2
Igf2bp2
Sfrs10
Etv5
Dgkg
Crygs
Tbccd1

Multiple QTL model fitting was performed to determine whether the proximal locus (at DNA marker rs13480775, 82.5 cM, 115.206 Mb) and distal locus (at rs13480796, 93.0 cM, 121.228 Mb) on Chr 10 are independent of one another in explaining variation in acetic acid-induced abdominal extension behavior in the BXD HHM group. The additive model containing the two loci on Chr 10 had a significant LOD score of 3.75 (p < 0.01) and the variance accounted for (VAF) was 51.3% of the total trait variance. Dropping rs13480775 from the model accounted for significantly less variance than the full model (LOD score drop of 1.57; χ2 df = 1 = 7.23, p < 0.05) as rs13480775 accounts for 34.3% of the phenotypic variance. Dropping rs13480796 from the model did not significantly affect the LOD score (drop of 0.04; χ2 df = 1 = 0.18, p = 0.67). Thus, while the proximal locus is sufficient to account for the phenotypic variation in the BXD HHM data, the inclusion of the distal locus does not significantly improve the fit of the model. Note that even though a single locus model including only the distal locus explains a significant amount of variability in the HHM group (LOD = 2.19; p < 0.01; VAF = 34.3%), and Fisher’s method detected a statistically significant locus at the distal marker, overall, it cannot be concluded that the proximal and distal loci on Chr 10 are independent of each other.

A similar approach was used to determine whether the two loci on Chr 16, at markers rs4165069 (9.90 cM, 17.57 Mb) and rs4165279 (12.01 cM, 21.24 Mb), are independent of each other in explaining variation in the BXD HHM group. The additive model containing both loci had a significant LOD score of 4.64 (p < 0.001) and accounted for 58.9% of the trait variance. Dropping rs4165069 from the model did not significantly affect the LOD score (drop of 0.07; χ2 df = 1 = 0.34, p = 0.84), and dropping rs4165279 resulted in a LOD score decrease of 1.16 (χ2 df = 1 = 5.33, p = 0.07). Thus, whereas inclusion of the proximal locus does not significantly improve the fit of the model, it cannot be concluded that the proximal and distal loci on Chr 16 are independent of each other.

3.3. Transcript covariance analysis and convergence with QTL mapping results

Thirty-one transcripts had high abundance covariance with acetic acid response means (|r| ≥ 0.6, p < 0.0001) in two or more of the HHF, HHM or RQM BXD RI groups (Table 2). Of particular interest are the genes Dclk1, Eif2a, and Wwtr1, which are the only genes with high transcript covariance and that are also found in the detected QTLs, in this case all on Chr 3 (Tables 2 and 3). Expression of Dclk1 in the prefrontal cortex is highly negatively correlated with response means of all three groups (−0.73 < r < −0.64), and expression in the nucleus accumbens is highly negatively correlated with response means of two of the groups (−0.80 < r < −0.66) (Table 3). Expression of Eif2a in the prefrontal cortex is highly negatively correlated with response means of all three groups (−0.79 < r < −0.68) and expression of Wwtr1 in the striatum is highly negatively correlated with response means of two of the groups (−0.75 < r < −0.61) (Table 3).

Table 2.

Genes showing high transcript covariance with acetic acid response means (|r| ≥ 0.6 with indicated groups, p < 0.0001 for one or more groups). Genes indicated with bold font are also found in the significant QTLs shown in Figures 24.

Brain Area
(Strains in
common)
HHF
+ HHM
+ RMQ
HHM
+ RMQ
HHF
+
RMQ
HHF
+ HHM
Cerebelluma
Hippocampusb Eef1g Adk5
Lbp Gab1
Noc4
Neocortex c Cdcc122 Igfbp4 Dph5
Usp12 Man2b1
Slc41a2
Nucleus
accumbensd
Bace Dclk1
Chmp4b
Dpcd
Ewsr1
Map2k6
Nat11
Pomp
Rbx1
Terf1
Timm17a
Zfp358
Prefrontal
cortexe
Dclk1 Mfap3 Asb1
Dusp12 Cyyr1
Eif2a
Striatumf Fancd2 HBP*
Ssh3 HBP*
Wwtr1HQF*
a

GE-NIAAA Cerebellum mRNA M430v2 (May05) RMA and SJUT Cerebellum mRNA M430 (Mar05) RMA microarray datasets;

b

Hippocampus Consortium M430v2 (Jun06) RMA dataset;

c

HQF BXD Neocortex ILM6v1.1 (Feb08) RankInv dataset;

d

VCU BXD NA Sal M430 2.0 (Oct07) RMA dataset;

e

VCU BXD PFC Sal M430 2.0 (Dec06) RMA;

f,*

HQF Striatum Exon (Feb09) RMA and HBP Rosen Striatum M430V2 (Apr05) RMA Clean datasets. See www.genenetwork.org for complete details of each dataset.

Table 3.

Correlations and p-values of candidate genes for inflammatory nociception found in significant QTL regions (indicated in bold in Tables 1 and 2) showing high transcript expression covariance with acetic acid response means.

Gene
Symbol
Gene Name Chr Mb
range
Brain Area Pearson Correlation Correlation p-value
HHF HHM RMQ HHF HHM RMQ
Dclk1 Doublecortin-like kinase 1 3 55.047–55.341 Prefrontal cortex −0.73 −0.64 −0.71 0.000084 0.0012 0.00084
Dclk1 Doublecortin-like kinase 1 3 55.047–55.341 Nucleus accumbens −0.80 −0.57 −0.66 0.0000025 0.0055 0.0029
Eif2a Eukaryotic translation initiation factor 2a 3 58.330–58.361 Prefrontal cortex −0.72 −0.68 −0.79 0.00012 0.00050 0.000055
Wwtr1 WW domain containing transcription regulator 3 57.260–57.380 Striatum −0.61 −0.55 −0.75 0.0012 0.0047 0.000063

4. Discussion

As for many other sensory, nociceptive and antinociceptive traits examined previously in inbred mouse strain panels, sensitivity to IP acetic acid shows marked strain differences and sufficient heritability in the BXD RI mice to merit further investigation into, and identification of, the underlying genetic mechanisms. Whole-genome QTL mapping detected genomic loci containing high priority candidate genes for inflammatory nociception, including a novel locus on Chr 3, loci on Chr 10 that overlap with a previously detected region, and a novel sex-specific locus on Chr 16.

Significant linkage was detected between acetic acid induced inflammatory nociception and a locus on Chr 3 that showed highly similar and consistent mapping results across all three groups of BXD mice (HHF, HHM and RMQ). This QTL peak is distinct from those previously identified for other sensory traits and includes several genes for P2Y receptors (P2ry12, P2ry13 and P2ry14) recently implicated in inflammatory pain models [24], and other G protein coupled receptors. However, a comparison with gene expression data in the BXD RI strains provides convergent evidence for other candidate genes in the region. Three candidate genes located in the QTL on Chr 3 also show high covariation of transcript expression profiles in the prefrontal cortex, nucleus accumbens or striatum with acetic acid responding in two or more groups of BXD RI mice: Dclk1, which encodes doublecortin-like kinase 1; Eif2a, encoding for eukaryotic translation initiation factor 2a; and Wwtr1, encoding for WW domain containing transcription regulator 1. A recent report has shown that inflammatory nociception induced by subcutaneous injection of paraformaldehyde in the rat hind paw increases the number of neurons with immunoreactivity to phosphorylated doublecortin-like kinase (pDCLK) and the specific signal density for pDCLK in the non-preganglionic Edinger-Westphal nucleus [39]. Although the 14-3-3 family of proteins, of which Wwtr1 encodes a binding protein, have recently been implicated in inflammatory processes [54], and Eif2a has a recognized role in cellular stress responses [34], at present, it is not known what role these genes play in visceral inflammatory nociception. Thus, although the convergent QTL mapping and expression findings suggest that these genes merit further study for possible roles in inflammatory nociception, these or other candidate genes in the linked region may be responsible for the QTL on Chr 3.

Based on quantitative combination of the results of the three BXD groups (with Fisher’s method), a locus on distal Chr 10 was detected with significant linkage to acetic acid responses and a second slightly more proximal locus was found very close to significantly linked and may be male-specific. These QTLs are in the same region as Nociq2, the QTL previously linked to murine sensitivity in the early and late phases of the intraplantar formalin test of inflammatory nociception [52]. Although the current results may appear to resolve Nociq2 into two loci as previously suspected but not concluded upon [52], multiple QTL modeling performed in the current study does not permit the conclusion that there are two independent loci. The loci cannot be quantitatively distinguished, due to linkage between the loci in the BXD RI strains, but it also cannot be concluded that the two loci are in fact a single locus. Thus, further analysis is necessary to determine if, in fact, there are at least two candidate genes underlying inflammatory nociception in the distal portion of Chr 10. The candidate genes in the more distal significant QTL are listed in Table 1. Wif1 is a candidate gene located in the more distal locus that encodes for Wnt inhibitory factor 1 that might play a significant role in inflammatory nociception as Wnt signaling pathways have been implicated in inflammatory bowel disease and rheumatoid arthritis, and they show activation by inflammation and, in turn, upregulate pro-inflammatory genes [15,43,48]. Avpr1a might also play a role in inflammatory nociception as the arginine vasopression (AVP) receptor encoded for by Avpr1a has been shown to mediate analgesia activated by endogenous ligands of the receptor [19,41]. Candidate genes responsible for the significant QTL are currently under investigation by us and others.

Consistent with previous reports of outbred mouse strains [30] and for inflammatory nociception [52], in the current study females were slightly to several fold more sensitive than males in the vast majority of BXD strains. In only two BXD strains were females at least slightly, but not significantly, less sensitive than males. The current study detected novel, sex-specific linkage of inflammatory nociception to a region of Chr 16. This region shows statistically significant linkage in the HHM group of male BXD mice but not in the HHF group of female mice of the same experiment. Note that the RMQ group of male mice shows a similar mapping pattern that may not have been adequately sensitive to reach statistically significant levels possibly due to the truncated observation period of this group. At present, convergent evidence for specific candidate genes in the significant QTL peak on Chr 16 is not yet available, and thus it remains to be determined which candidate gene is responsible for the QTL.

Convergent prior evidence does exist for the candidate gene Comt1 located at 18.407–18.427 Mb in the more proximal, male-specific, statistically suggestive QTL peak on Chr 16 reported here (Fig. 4). Comt1 encodes the enzyme catechol-O-methyltransferase (COMT) that metabolizes catecholamines including epinephrine, norepinephrine and dopamine. In humans, the genotype (haplotype) for COMT associated with decreased COMT activity has been associated with increased pain sensitivity to noxious experimental stimuli and increased risk for temporomandibular joint pain disorder [10,11]. In rodents, inhibitors of COMT enzyme activity increase nociceptive sensitivity in rodents [11]. We recently reported that the genotype and expression of Comt1 in standard inbred strains of mice is predictive of sensitivity in six assays of inflammatory nociception, including IP injection of acetic acid or magnesium sulfate, and subcutaneous injection of formalin, capsaicin, or bee venom [42]. Specifically, standard inbred strains such as the BXD progenitor strain DBA/2J that lack a novel B2 short interspersed nuclear element (SINE) found in the 3’ UTR region of Comt1 are more sensitive to inflammatory nociception (but not inflammation-induced hypersensitivity) than strains with the SINE element including C57BL/6J [42], due to a premature polyadenylation signal and increased COMT protein expression [42]. The genotype of BXD RI strains at this precise locus is not yet known. Overall, Comt1 or other candidate genes in the suggestive and significant QTLs on Chr 16 may represent mechanisms that modulate inflammatory nociception only in males and thus may indirectly underlie the increased sensitivity of females to inflammatory nociception.

The current study represents only the second genome-wide study of genetic mechanisms underlying heritable variability in sensitivity to inflammatory nociception. The results confirm earlier findings indicating shared genetic mechanisms between the assays of formalin-induced and acetic acid-induced inflammatory nociceptive behavior in standard inbred mice [23,33] and provide specific potential candidate genes for subsequent investigation in rodents and human association studies. Nociq2, the QTL for formalin-induced inflammatory nociception, has been replicated and may still be two loci with more than one candidate gene on distal Chr 10 underlying inflammatory nociception. In addition, novel regions of Chr 3 and Chr 16 have been found to be linked to inflammatory nociception with convergent evidence for several candidate genes in the regions. Finally, sex-specific linkage was detected on Chr 16 and may reveal mechanisms that differ between the sexes and provide sex-specific therapeutic targets. Additional studies are necessary to determine which of the identified candidate genes are responsible for the current results.

Acknowledgements

Research supported by the NIH 1R01DA021198 (W.R.L), and NIH Grant DE-06894, BRSG S07RR 05369 and a Merit Review Grant from the Department of Veterans Affairs (J.K.B.).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest Statement

The authors have no conflicts of interest to report.

References

  • 1.Ansah OB, Leite-Almeida H, Wei H, Pertovaara A. Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat. Exp Neurol. 2007;205:536–546. doi: 10.1016/j.expneurol.2007.03.010. [DOI] [PubMed] [Google Scholar]
  • 2.Bian F, Li Z, Offord J, Davis MD, McCormick J, Taylor CP, Walker LC. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res. 2006;1075:68–80. doi: 10.1016/j.brainres.2005.12.084. [DOI] [PubMed] [Google Scholar]
  • 3.Chesler EJ, Lu L, Shou S, Qu Y, Gu J, Wang J, Hsu HC, Mountz JD, Baldwin NE, Langston MA, Threadgill DW, Manly KF, Williams RW. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet. 2005;37:233–242. doi: 10.1038/ng1518. [DOI] [PubMed] [Google Scholar]
  • 4.Chesler EJ, Lu L, Wang J, Williams RW, Manly KF. WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nat Neurosci. 2004;7:485–486. doi: 10.1038/nn0504-485. [DOI] [PubMed] [Google Scholar]
  • 5.Chesler EJ, Wang J, Lu L, Qu Y, Manly KF, Williams RW. Genetic correlates of gene expression in recombinant inbred strains: a relational model system to explore neurobehavioral phenotypes. Neuroinformatics. 2003;1:343–357. doi: 10.1385/NI:1:4:343. [DOI] [PubMed] [Google Scholar]
  • 6.Chesler EJ, Williams RW. Brain gene expression: genomics and genetics. Int Rev Neurobiol. 2004;60:59–95. doi: 10.1016/S0074-7742(04)60003-1. [DOI] [PubMed] [Google Scholar]
  • 7.Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963–971. doi: 10.1093/genetics/138.3.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Costigan M, Befort K, Karchewski L, Griffin RS, D'Urso D, Allchorne A, Sitarski J, Mannion JW, Pratt RE, Woolf CJ. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci. 2002;3:16. doi: 10.1186/1471-2202-3-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Crabbe JC, Phillips TJ, Kosobud A, Belknap JK. Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res. 1990;14:141–151. doi: 10.1111/j.1530-0277.1990.tb00461.x. [DOI] [PubMed] [Google Scholar]
  • 10.Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006;125:216–224. doi: 10.1016/j.pain.2006.05.024. [DOI] [PubMed] [Google Scholar]
  • 11.Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14:135–143. doi: 10.1093/hmg/ddi013. [DOI] [PubMed] [Google Scholar]
  • 12.Drake TA, Schadt EE, Lusis AJ. Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice. Mamm Genome. 2006;17:466–479. doi: 10.1007/s00335-005-0175-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Duquette M, Roy M, Lepore F, Peretz I, Rainville P. Cerebral mechanisms involved in the interaction between pain and emotion. Rev Neurol (Paris) 2007;163:169–179. doi: 10.1016/s0035-3787(07)90388-4. [DOI] [PubMed] [Google Scholar]
  • 14.Falconer DS, Mackay TFC. Introduction to Quantitative Genetics. Vol. 4. Essex, UK: Longman; 1996. [Google Scholar]
  • 15.George SJ. Wnt pathway: a new role in regulation of inflammation. Arterioscler Thromb Vasc Biol. 2008;28:400–402. doi: 10.1161/ATVBAHA.107.160952. [DOI] [PubMed] [Google Scholar]
  • 16.Griffin RS, Costigan M, Brenner GJ, Ma CH, Scholz J, Moss A, Allchorne AJ, Stahl GL, Woolf CJ. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J Neurosci. 2007;27:8699–8708. doi: 10.1523/JNEUROSCI.2018-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hagelberg N, Jaaskelainen SK, Martikainen IK, Mansikka H, Forssell H, Scheinin H, Hietala J, Pertovaara A. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol. 2004;500:187–192. doi: 10.1016/j.ejphar.2004.07.024. [DOI] [PubMed] [Google Scholar]
  • 18.Hegmann JP, Possidente B. Estimating genetic correlations from inbred strains. Behav Genet. 1981;11:103–114. doi: 10.1007/BF01065621. [DOI] [PubMed] [Google Scholar]
  • 19.Honda K, Takano Y. New topics in vasopressin receptors and approach to novel drugs: involvement of vasopressin V1a and V1b receptors in nociceptive responses and morphine-induced effects. J Pharmacol Sci. 2009;109:38–43. doi: 10.1254/jphs.08r30fm. [DOI] [PubMed] [Google Scholar]
  • 20.Lacroix-Fralish ML, Ledoux JB, Mogil JS. The Pain Genes Database: An interactive web browser of pain-related transgenic knockout studies. Pain. 2007;131:3. doi: 10.1016/j.pain.2007.04.041. e1-4. [DOI] [PubMed] [Google Scholar]
  • 21.LaCroix-Fralish ML, Mo G, Smith SB, Sotocinal SG, Ritchie J, Austin JS, Melmed K, Schorscher-Petcu A, Laferriere AC, Lee TH, Romanovsky D, Liao G, Behlke MA, Clark DJ, Peltz G, Seguela P, Dobretsov M, Mogil JS. The beta3 subunit of the Na+,K+-ATPase mediates variable nociceptive sensitivity in the formalin test. Pain. 2009;144:294–302. doi: 10.1016/j.pain.2009.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lander ES, Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics. 1989;121:185–199. doi: 10.1093/genetics/121.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lariviere WR, Wilson SG, Laughlin TM, Kokayeff A, West EE, Adhikari SM, Wan Y, Mogil JS. Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity. Pain. 2002;97:75–86. doi: 10.1016/s0304-3959(01)00492-4. [DOI] [PubMed] [Google Scholar]
  • 24.Malin SA, Molliver DC. Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Mol Pain. 2010;6:21. doi: 10.1186/1744-8069-6-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mangin B, Goffinet B. Comparison of several confidence intervals for QTL location. Heredity. 1997;78:345–353. [Google Scholar]
  • 26.Mangin B, Goffinet B, Rebai A. Constructing confidence intervals for QTL location. Genetics. 1994;138:1301–1308. doi: 10.1093/genetics/138.4.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Manly KF, Cudmore RH, Jr, Meer JM. Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome. 2001;12:930–932. doi: 10.1007/s00335-001-1016-3. [DOI] [PubMed] [Google Scholar]
  • 28.Manly KF, Olson JM. Overview of QTL mapping software and introduction to map manager QT. Mamm Genome. 1999;10:327–334. doi: 10.1007/s003359900997. [DOI] [PubMed] [Google Scholar]
  • 29.McClearn GE. Contextual genetics. Trends Genet. 2006;22:314–319. doi: 10.1016/j.tig.2006.04.005. [DOI] [PubMed] [Google Scholar]
  • 30.Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev. 2000;24:375–389. doi: 10.1016/s0149-7634(00)00015-4. [DOI] [PubMed] [Google Scholar]
  • 31.Mogil JS, Richards SP, O'Toole LA, Helms ML, Mitchell SR, Kest B, Belknap JK. Identification of a sex-specific quantitative trait locus mediating nonopioid stress-induced analgesia in female mice. J Neurosci. 1997;17:7995–8002. doi: 10.1523/JNEUROSCI.17-20-07995.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mogil JS, Ritchie J, Sotocinal SG, Smith SB, Croteau S, Levitin DJ, Naumova AK. Screening for pain phenotypes: analysis of three congenic mouse strains on a battery of nine nociceptive assays. Pain. 2006;126:24–34. doi: 10.1016/j.pain.2006.06.004. [DOI] [PubMed] [Google Scholar]
  • 33.Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. Heritability of nociception II. 'Types' of nociception revealed by genetic correlation analysis. Pain. 1999;80:83–93. doi: 10.1016/s0304-3959(98)00196-1. [DOI] [PubMed] [Google Scholar]
  • 34.Park KM, Kim DJ, Paik SG, Kim SJ, Yeom YI. Role of E2F1 in endoplasmic reticulum stress signaling. Mol Cells. 2006;21:356–359. [PubMed] [Google Scholar]
  • 35.Peirce JL, Chesler EJ, Williams RW, Lu L. Genetic architecture of the mouse hippocampus: identification of gene loci with selective regional effects. Genes Brain Behav. 2003;2:238–252. doi: 10.1034/j.1601-183x.2003.00030.x. [DOI] [PubMed] [Google Scholar]
  • 36.Peirce JL, Li H, Wang J, Manly KF, Hitzemann RJ, Belknap JK, Rosen GD, Goodwin S, Sutter TR, Williams RW, Lu L. How replicable are mRNA expression QTL? Mamm Genome. 2006;17:643–656. doi: 10.1007/s00335-005-0187-8. [DOI] [PubMed] [Google Scholar]
  • 37.Quock RM, Mueller JL, Vaughn LK, Belknap JK. Nitrous oxide antinociception in BXD recombinant inbred mouse strains and identification of quantitative trait loci. Brain Res. 1996;725:23–29. doi: 10.1016/0006-8993(96)00211-9. [DOI] [PubMed] [Google Scholar]
  • 38.Robinson DR, Gebhart GF. Inside information: the unique features of visceral sensation. Mol Interv. 2008;8:242–253. doi: 10.1124/mi.8.5.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Rouwette TP, Kozicz T, Olde Loohuis NF, Gaszner B, Vreugdenhil E, Scheffer GJ, Roubos EW, Vissers KC, Scheenen WJ. Acute Pain Increases Phosphorylation of DCLK-Long in the Edinger-Westphal Nucleus but not in the Hypothalamic Paraventricular Nucleus of the Rat. J Pain. doi: 10.1016/j.jpain.2009.12.017. in press. [DOI] [PubMed] [Google Scholar]
  • 40.Saab CY, Willis WD. The cerebellum: organization, functions and its role in nociception. Brain Res Brain Res Rev. 2003;42:85–95. doi: 10.1016/s0165-0173(03)00151-6. [DOI] [PubMed] [Google Scholar]
  • 41.Schorscher-Petcu A, Sotocinal S, Ciura S, Dupre A, Ritchie J, Sorge RE, Crawley JN, Hu SB, Nishimori K, Young LJ, Tribollet E, Quirion R, Mogil JS. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci. 2010;30:8274–8284. doi: 10.1523/JNEUROSCI.1594-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Segall S, Nackley AG, Diatchenko L, Lariviere WR, Lu X, Marron JS, Grabowski-Boase L, Walker JR, Slade G, Gauthier J, Bailey JS, Steffy BM, Maynard TM, Tarantino LM, Wiltshire T. Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice. Genes Brain Behav. 2010;9:933–946. doi: 10.1111/j.1601-183X.2010.00633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Sen M. Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford) 2005;44:708–713. doi: 10.1093/rheumatology/keh553. [DOI] [PubMed] [Google Scholar]
  • 44.Sokol RR, Rohlf FJ. Biometry. San Francisco, CA: W.H. Freeman and Company; 1981. [Google Scholar]
  • 45.Taylor BA. Recombinant inbred strains: Use in gene mapping. In: Morse HCI, editor. Origins of Inbred Mice. NY: Academic Press; 1978. pp. 423–438. [Google Scholar]
  • 46.Taylor BK, Joshi C, Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res. 2003;987:135–143. doi: 10.1016/s0006-8993(03)03318-3. [DOI] [PubMed] [Google Scholar]
  • 47.Tjølsen A, Berge O-G, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992;51:5–17. doi: 10.1016/0304-3959(92)90003-T. [DOI] [PubMed] [Google Scholar]
  • 48.Valdes AM, Spector TD. The clinical relevance of genetic susceptibility to osteoarthritis. Best Pract Res Clin Rheumatol. 2010;24:3–14. doi: 10.1016/j.berh.2009.08.005. [DOI] [PubMed] [Google Scholar]
  • 49.Visscher PM, Thompson R, Haley CS. Confidence intervals in QTL mapping by bootstrapping. Genetics. 1996;143:1013–1020. doi: 10.1093/genetics/143.2.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Walling GA, Haley CS, Perez-Enciso M, Thompson R, Visscher PM. On the mapping of quantitative trait loci at marker and non-marker locations. Genet Res. 2002;79:97–106. doi: 10.1017/s0016672301005420. [DOI] [PubMed] [Google Scholar]
  • 51.Wang J, Williams RW, Manly KF. WebQTL: web-based complex trait analysis. Neuroinformatics. 2003;1:299–308. doi: 10.1385/NI:1:4:299. [DOI] [PubMed] [Google Scholar]
  • 52.Wilson SG, Chesler EJ, Hain H, Rankin AJ, Schwarz JZ, Call SB, Murray MR, West EE, Teuscher C, Rodriguez-Zas S, Belknap JK, Mogil JS. Identification of quantitative trait loci for chemical/inflammatory nociception in mice. Pain. 2002;96:385–391. doi: 10.1016/S0304-3959(01)00489-4. [DOI] [PubMed] [Google Scholar]
  • 53.Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110. doi: 10.1016/0304-3959(83)90201-4. [DOI] [PubMed] [Google Scholar]
  • 54.Zuo S, Xue Y, Tang S, Yao J, Du R, Yang P, Chen X. 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-alpha-induced time course-dependent NF-kappaB activity. J Proteome Res. 2010;9:3465–3478. doi: 10.1021/pr9011377. [DOI] [PubMed] [Google Scholar]

RESOURCES